期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 118, 期 3, 页码 1056-1064出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI33871
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
Elevated intraocular pressure (IOP) is the principal risk factor for glaucoma and results from excessive impedance of the fluid outflow from the eye. This abnormality likely originates from outflow pathway tissues such as the trabecular meshwork (TM), but the associated molecular etiology is poorly understood. We discovered what we believe to be a novel role for secreted frizzled-related protein-1 (sFRP-1), an antagonist of Writ signaling, in regulating IOP. sFPP1 was overexpressed in human glaucomatous TM cells. Genes involved in the Wnt signaling pathway were expressed in cultured TM cells and human TM tissues. Addition of recombinant sFRP-1 to ex vivo perfusion-cultured human eyes decreased outflow facility, concomitant with reduced levels of beta-catenin, the Writ signaling mediator, in the TM. Intravitreal injection of an adenoviral vector encoding sFRP1 in mice produced a titer-dependent increase in IOP. Five days after vector injection, IOP increased 2 fold, which was significantly reduced by topical ocular administration of an inhibitor of a downstream suppressor of Writ signaling. Thus, these data indicate that increased expression of sFPP1 in the TM appears to be responsible for elevated IOP in glaucoma and restoring Writ signaling in the TM may be a novel disease intervention strategy for treating glaucoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据